Aytu BioPharma, Inc. - stock earnings
AYTU Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -220000 USD | 22.9 million USD |
| 2023Q3 | -2.5 million USD | 30.7 million USD |
| 2023Q2 | -2.5 million USD | 30.7 million USD |
| 2023Q1 | -5.8 million USD | 22.7 million USD |
| 2022Q4 | -10.4 million USD | 26.3 million USD |
| 2022Q3 | -4.2 million USD | 27.7 million USD |
| 2022Q2 | -38.1 million USD | 27.4 million USD |
| 2022Q1 | -140.3 million USD | 24.2 million USD |
| 2021Q4 | -11.5 million USD | 23.1 million USD |
| 2021Q3 | -27.9 million USD | 21.9 million USD |
| 2021Q2 | -19.0 million USD | 23.5 million USD |
| 2021Q1 | -25.5 million USD | 13.5 million USD |
| 2020Q4 | -9.5 million USD | 15.1 million USD |
| 2020Q3 | -3.1 million USD | 14.9 million USD |
| 2020Q2 | -3.1 million USD | 14.9 million USD |
| 2020Q1 | -5.3 million USD | 8.2 million USD |
| 2019Q4 | -214247 USD | 3.2 million USD |
| 2019Q3 | -4.9 million USD | 1.4 million USD |
| 2019Q2 | -14.5 million USD | 1.7 million USD |
| 2019Q1 | -4.5 million USD | 2.4 million USD |
| 2018Q4 | -4.7 million USD | 1.8 million USD |
| 2018Q3 | -3.4 million USD | 1.4 million USD |
| 2018Q2 | 547569 USD | 925000 USD |
| 2018Q1 | -2.8 million USD | 607000 USD |
| 2017Q4 | -3.7 million USD | 1.1 million USD |
| 2017Q3 | -4.2 million USD | 1.1 million USD |
| 2017Q2 | -3.0 million USD | 835889 USD |
| 2017Q1 | -5.2 million USD | 894000 USD |
| 2016Q4 | -4.8 million USD | 794000 USD |
| 2016Q3 | -5.7 million USD | 698000 USD |
| 2016Q2 | -15.3 million USD | 937305 USD |
| 2016Q1 | -7.3 million USD | 668429 USD |
| 2015Q4 | -3.3 million USD | 469428 USD |
| 2015Q3 | -2.3 million USD | 487385 USD |
| 2015Q2 | -2.2 million USD | 182036 USD |
| 2015Q1 | -1.8 million USD | 23829 USD |
| 2014Q4 | -15754 USD | 23829 USD |
| 2014Q3 | -11196 USD | 27000 USD |
| 2014Q2 | -11824 USD | 1000 USD |
| 2014Q1 | -22196 USD | 1000 USD |
| 2013Q4 | -16507 USD | ? USD |
| 2013Q3 | -10536 USD | -3500 USD |
| 2013Q2 | -13265 USD | 1750 USD |
| 2013Q1 | -13659 USD | 1750 USD |
| 2012Q4 | -19859 USD | ? USD |
| 2012Q3 | -17988 USD | 1750 USD |
| 2012Q2 | -17988 USD | 1750 USD |
| 2012Q1 | -10079 USD | ? USD |
| 2011Q4 | -10079 USD | ? USD |
| 2011Q3 | -71537 USD | ? USD |
| 2011Q2 | -20715 USD | ? USD |
| 2011Q1 | -26835 USD | ? USD |
| 2010Q4 | -17715 USD | ? USD |
| 2010Q3 | -14071 USD | ? USD |
| 2010Q2 | -14901 USD | 1750 USD |
| 2010Q1 | -12232 USD | ? USD |
| 2009Q4 | -19066 USD | ? USD |
| 2009Q3 | -11235 USD | -1750 USD |
| 2009Q2 | -9533 USD | 1750 USD |
| 2009Q1 | -15895 USD | 1750 USD |
| 2008Q4 | -22230 USD | ? USD |
| 2008Q3 | -12392 USD | ? USD |
| 2008Q2 | -17885 USD | ? USD |
| 2008Q1 | -11137 USD | ? USD |
| 2007Q4 | -15759 USD | ? USD |
| 2007Q3 | -11703 USD | ? USD |
| 2007Q2 | -14256 USD | ? USD |
| 2007Q1 | -14256 USD | ? USD |
| 2006Q4 | -15486 USD | ? USD |
| 2006Q3 | -7510 USD | ? USD |
| 2006Q1 | -1905 USD | ? USD |
AYTU Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -17.1 million USD | 107.4 million USD |
| 2022 | -110.2 million USD | 96.7 million USD |
| 2021 | -58.3 million USD | 65.6 million USD |
| 2020 | -3.7 million USD | 27.6 million USD |
| 2019 | -47.2 million USD | 7.3 million USD |
| 2018 | -10.2 million USD | 3.7 million USD |
| 2017 | -22.5 million USD | 3.2 million USD |
| 2016 | -28.2 million USD | 2.6 million USD |
| 2015 | -7.7 million USD | 261782 USD |
| 2014 | -5.6 million USD | 58929 USD |
| 2013 | -57318 USD | 1750 USD |
| 2012 | -59675 USD | 1750 USD |
| 2011 | -136802 USD | ? USD |
| 2010 | -60270 USD | ? USD |
| 2009 | -58894 USD | 1750 USD |
| 2008 | -57173 USD | ? USD |
| 2007 | -48954 USD | ? USD |
AYTU
Price: $2.90
52 week price:
Earnings Per Share: -4.01 USD
P/E Ratio: -0.45
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 55600
Ebitda: -9.2 millionMarket Capitalization: 17.9 million